| abstract |
The present invention relates to compounds of the general formula (I) and pharmaceutically acceptable salts thereof.n n n n n n n n Wherein X is alkyl, Y is a single bond, -CH 2- , -C (0)-, -0-, -S- or -N (R 8 )-, wherein R 8 is hydrogen, alkyl, halo Alkyl, aryl, arylalkyl, cycloalkyl or (cycloalkyl) alkyl, and R 1 to R 8 are as defined herein. These compounds have a potassium channel activating action and are therefore useful, for example, as a cardiovascular agent. |